The Long Run with Luke Timmerman
Ep201: Jeremy Levin on Biotech in the Balance
Dienstag, 19. Mai 2026 · 1 h 09
Kapitelklicken springt direkt hin
Shownotes
Jeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."